Search research articles
Contact Us
Filters
Showing results (21-30 of 106) with videos related to
Page
of 11
Sort By:
Hematological Oncology
|
September 23, 2025
A SWOT-Consensus for CAR-T in Follicular Lymphoma: Fine Tuning of Patient Journey and Selection
Monia Marchetti, Paolo Corradini, Luca Arcaini, et al.
Hematological Oncology
|
November 28, 2025
Managing Treatment-Emergent Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome Following CAR-T Cell Therapy: A Case-Based Review of the use of Emapalumab
Livia Donzelli, Veronica Zullino, Giovanni Fernando Torelli, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 26, 2026
PET-guided early identification of CAR-T candidates in diffuse large b-cell lymphoma: a multidisciplinary expert consensus
Luca Guerra, Domenico Albano, Piera Angelillo, et al.
Leukemia & Lymphoma
|
May 19, 2022
Bing-Neel syndrome coexisting with oligodendroglioma
Livia Donzelli, Clara Minotti, Giovanni Fernando Torelli, et al.
Global & Regional Health Technology Assessment
|
June 11, 2026
Optimizing CAR-T therapy delivery in the Italian healthcare system: economic and organizational insights in follicular lymphoma
Andrea Vitagliano, Marzia Bonfanti, Emanuele Angelucci, et al.
Current Research in Translational Medicine
|
November 19, 2025
Sustained remission in relapsed/refractory diffuse large B cell lymphoma following Glofitamab discontinuation due to JC virus reactivation: balancing efficacy and infectious risk
Massimiliano Marinoni, Lucrezia De Marchi, Federico Meconi, et al.
Leukemia & Lymphoma
|
October 25, 2021
Donor cell derived mantle cell lymphoma in a HSCT sibling donor-recipient pair: intrinsic biological clock in lymphomagenesis
Paolo Musiu, Luisa Quattrocchi, Walter Barberi, et al.
British Journal of Haematology
|
August 1, 2019
Thrombopoietin receptor agonists to control immune thrombocytopenia in patients with active lymphoma
Antonietta Ferretti, Erminia Baldacci, Eleonora Miulli, et al.
Cytotherapy
|
September 10, 2025
Overcoming barriers to referral for CAR T-cell therapy in patients with non-Hodgkin aggressive B-cell lymphomas: A Delphi consensus
Stefano Luminari, Annalisa Chiappella, Alice Di Rocco, et al.
Frontiers in Oncology
|
July 3, 2023
Case Report: Severe cutaneous adverse event associated with checkpoint inhibition in the setting of CAR T-cell therapy: beyond CRS
Chiara Masucci, Sara Pepe, Ursula La Rocca, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 106) with videos related to
Sort By:
Page
of 11
Hematological Oncology
|
September 23, 2025
A SWOT-Consensus for CAR-T in Follicular Lymphoma: Fine Tuning of Patient Journey and Selection
Monia Marchetti, Paolo Corradini, Luca Arcaini, et al.
Hematological Oncology
|
November 28, 2025
Managing Treatment-Emergent Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome Following CAR-T Cell Therapy: A Case-Based Review of the use of Emapalumab
Livia Donzelli, Veronica Zullino, Giovanni Fernando Torelli, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 26, 2026
PET-guided early identification of CAR-T candidates in diffuse large b-cell lymphoma: a multidisciplinary expert consensus
Luca Guerra, Domenico Albano, Piera Angelillo, et al.
Leukemia & Lymphoma
|
May 19, 2022
Bing-Neel syndrome coexisting with oligodendroglioma
Livia Donzelli, Clara Minotti, Giovanni Fernando Torelli, et al.
Global & Regional Health Technology Assessment
|
June 11, 2026
Optimizing CAR-T therapy delivery in the Italian healthcare system: economic and organizational insights in follicular lymphoma
Andrea Vitagliano, Marzia Bonfanti, Emanuele Angelucci, et al.
Current Research in Translational Medicine
|
November 19, 2025
Sustained remission in relapsed/refractory diffuse large B cell lymphoma following Glofitamab discontinuation due to JC virus reactivation: balancing efficacy and infectious risk
Massimiliano Marinoni, Lucrezia De Marchi, Federico Meconi, et al.
Leukemia & Lymphoma
|
October 25, 2021
Donor cell derived mantle cell lymphoma in a HSCT sibling donor-recipient pair: intrinsic biological clock in lymphomagenesis
Paolo Musiu, Luisa Quattrocchi, Walter Barberi, et al.
British Journal of Haematology
|
August 1, 2019
Thrombopoietin receptor agonists to control immune thrombocytopenia in patients with active lymphoma
Antonietta Ferretti, Erminia Baldacci, Eleonora Miulli, et al.
Cytotherapy
|
September 10, 2025
Overcoming barriers to referral for CAR T-cell therapy in patients with non-Hodgkin aggressive B-cell lymphomas: A Delphi consensus
Stefano Luminari, Annalisa Chiappella, Alice Di Rocco, et al.
Frontiers in Oncology
|
July 3, 2023
Case Report: Severe cutaneous adverse event associated with checkpoint inhibition in the setting of CAR T-cell therapy: beyond CRS
Chiara Masucci, Sara Pepe, Ursula La Rocca, et al.
Page
of 11